share_log

太龙药业(600222.SH):目前引入的藿香正气合剂、五子衍宗口服液、生脉饮等产品均实现上市生产

henan taloph pharmaceutical stock (600222.SH): Currently, products such as Huoxiang Zhengqi Formula, Wuzi Yanzong Oral Liquid, and Shengmai Yin have all been successfully launched for production.

Gelonghui Finance ·  Oct 8, 2024 09:59

On October 8th, Henan Taloph Pharmaceutical Stock (600222.SH) stated in a recent performance briefing that the company adheres to the operation philosophy of being an expert in traditional chinese medicine oral liquids, market-driven, and in recent years has continuously increased the production of chinese patent medicine products through product introduction, research on classic formulas, and development of drugs with the same name and formula, promoting the diversified development of products and constructing a scientific product portfolio. Currently, products introduced such as the Huoxiang Zhengqi mixture, Wuzi Yanzong oral liquid, Shengmai Yin, have all been successfully launched for production.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment